Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease

被引：0

作者：

Sun Hye Shin

Hye Yun Park

Danbee Kang

Juhee Cho

Sung Ok Kwon

Joo Hun Park

Jae Seung Lee

Yeon-Mok Oh

Don D. Sin

Woo Jin Kim

Sang-Do Lee

机构：

[1] Sungkyunkwan University School of Medicine,Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center

[2] Sungkyunkwan University,Departments of Health Sciences and Technology and Clinical Research Design and Evaluation, Samsung Advanced Institute of Health Sciences and Technology

[3] Sungkyunkwan University School of Medicine,Cancer Education Center, Samsung Comprehensive Cancer Center, Samsung Medical Center

[4] Departments of Health,Biomedical Research Institute

[5] Behavior,Department of Pulmonary and Critical Care Medicine

[6] and Society and Epidemiology,Department of Pulmonary and Critical Care Medicine, Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center

[7] Johns Hopkins Bloomberg School of Public Health,Respiratory Division, Department of Medicine

[8] Kangwon National University Hospital,Department of Internal Medicine and Environmental Health Center

[9] Ajou University School of Medicine,undefined

[10] University of Ulsan College of Medicine,undefined

[11] University of British Columbia,undefined

[12] Kangwon National University Hospital,undefined

[13] School of Medicine,undefined

[14] Kangwon National University,undefined

来源：

Respiratory Research | / 19卷

关键词：

Chronic obstructive pulmonary disease; Eosinophil; Stability; Lung function;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 150 条

[1]

O'Donnell RA(2004)Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD Thorax 59 837-842

[2]

Peebles C(1998)Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis Am J Respir Crit Care Med 158 1511-1517

[3]

Ward JA(2005)Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease Thorax 60 193-198

[4]

Daraker A(2011)Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers Am J Respir Crit Care Med 184 662-671

[5]

Angco G(2012)Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial Am J Respir Crit Care Med 186 48-55

[6]

Broberg P(2016)Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD International Journal of Chronic Obstructive Pulmonary Disease 11 1495-1504

[7]

Pizzichini E(2016)Blood eosinophils as a marker of response to inhaled corticosteroids in COPD Eur Respir J 47 1374-1382

[8]

Pizzichini MM(2015)Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease Am J Respir Crit Care Med 192 523-525

[9]

Gibson P(2015)Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials Lancet Respir Med 3 435-442

[10]

Parameswaran K(2016)Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial Lancet Respir Med 4 390-398

← 1 2 3 4 5 6 7 8 9 10 →